Cite
HARVARD Citation
Monti, D. et al. (2019). N‐Acetyl Cysteine Is Associated With Dopaminergic Improvement in Parkinson's Disease. Clinical pharmacology & therapeutics. 106 (4), pp. 884-890. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Monti, D. et al. (2019). N‐Acetyl Cysteine Is Associated With Dopaminergic Improvement in Parkinson's Disease. Clinical pharmacology & therapeutics. 106 (4), pp. 884-890. [Online].